ClinicalTrials.Veeva

Menu

Prevalence of Non-alcoholic Fatty Liver Disease in Patients With Chronic Kidney Disease in Assiut

M

Muhammad Ameen Abdelrady Abdelaziz

Status

Not yet enrolling

Conditions

CKD
NAFLD

Study type

Observational

Funder types

Other

Identifiers

NCT06009250
NAFLD and CKD

Details and patient eligibility

About

The goal of this observational study is to detect the prevalence of NAFLD in CKD patients

The main question[s] it aims to answer are:

  • [question 1] prevalence of NAFLD in CKD patients.
  • [question 2] the relationship between NAFLD and CKD.

Full description

The goal of this observational study is to detect the prevalence of NAFLD in CKD patients

The main question[s] it aims to answer are:

  • [question 1] prevalence of NAFLD in CKD patients.
  • [question 2] the relationship between NAFLD and CKD.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • CKD patients

Exclusion criteria

  • HCV and HBV Positive patients
  • Alcoholics
  • patient on Hemodialysis
  • patients with wilson disease
  • patients with alpha one antitrypsin deficiency

Trial design

200 participants in 2 patient groups

CKD patients
Description:
CKD patient who are not DM are investigated for the presence of NAFLD
normal control group
Description:
normal population are investigated to know the prevalence of NAFLD in contrast to patients with CKD.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems